Patent ID: 11883571
Assignee: GAMBRO LUNDIA AB
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 13:
14. The method according to claim 13, wherein the adjustment contribution term is calculated as a function of at least one selected from the group consisting of:
(i) a concentration of two or more substances in the dialysis fluid selected from the group consisting of: bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate, and phosphate,
(ii) a difference in concentration of one or more substances in the dialysis fluid, and the corresponding same substances in the blood, the substances being chosen from the group consisting of: bicarbonate, potassium, acetate, lactate, and citrate,
(iii) molar conductivities of one or more substances in the dialysis fluid chosen from the group consisting of: sodium bicarbonate (NaHCO3), sodium chloride (NaCl), sodium acetate (NaCH3COO), potassium chloride (KCl), sodium lactate (NaC3H5O3), and trisodium citrate (Na3C6H5O7),
(iv) a difference between a first molar conductivity of a substance chosen from the group consisting of: sodium bicarbonate (NaHCO3), sodium acetate (NaCH3COO), trisodium citrate (Na3C6H5O7), sodium lactate (NaC3H5O3), potassium chloride (KCl), and a molar conductivity of sodium chloride (NaCl),
(v) an estimated or measured plasma water concentration of one or more substances chosen from the group consisting of: bicarbonate, potassium, acetate, lactate, and citrate, and
(vi) at least a ratio between a dialysate flow rate at the outlet of the secondary chamber and an efficiency parameter of the filtration unit.